^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    liraltagene autoleucel (lira-cel)

    i
    Other names: lira-cel, Ovarian cancer CAR-T therapy, Follicle Stimulating Hormone Receptor T Cells
    Associations
    News
    Trials
    Company:
    Anixa Biosci, Moffitt Cancer Center
    Drug class:
    FSHR-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials